*** For details on how to be removed from this list visit the *** *** CCP4 home page http://www.ccp4.ac.uk ***
Post-doctoral fellowship, X-ray Crystallography Suitable candidates will have a PhD in a relevant area of Structural Biology with extensive experience in most aspects of protein crystallography (including crystallisation, synchrotron data collection, structure solution and refinement). Candidates are expected to be team players and have a strong publication record. Practical experience in structural genomics is a definite advantage The successful candidate will be responsible for the structure determination of targets from SGC Stockholm target list and to assist in the running of the X-ray crystallography lab which includes a crystallisation robot, plate hotels and crystal imaging systems, micro-focus rotating anode X-ray generator, CCD X-ray detector and automatic sample changer. The fellowship (stipend) is offered on a fixed term of up to 24 months. General requirements to be eligible for this position are: I. Non-Swedish citizenship and II. Doctoral degree from a University outside Sweden. Starting date: March/April 2006 For further information contact: Dr. Derek Ogg ([EMAIL PROTECTED], +46 8 524 86843) Dr. Martin Hällberg ([EMAIL PROTECTED], +46 8 524 86856) Website: http://sgc.ki.se/ Please send your application by email to [EMAIL PROTECTED] no later than Jan 24, 2006. A list of at least two reference persons should be included. --------------------------------------------------------------- The Structural Genomics Consortium (SGC) is a not-for-profit organization that aims to determine the three dimensional structures of proteins of medical relevance, and place them in the public domain without restriction. The initiative was launched in Oxford and Toronto in April 2003 with funding from Canadian and British sponsors from both the public and private sectors (The Wellcome Trust, GlaxoSmithKline, Genome Canada, the Ontario Research and Development Challenge Fund, the Ontario Innovation Trust and the Canadian Institutes of Health Research). In 2005, a consortium of Swedish sponsors (VINNOVA, SSF, KAW and KI) provided funds to the SGC and a Swedish node was launched at the Karolinska Institutet. The goal of the SGC is to develop the infrastructure and technologies necessary for rapid, parallel structure determination, with the aim of having the capability to determine more than 200 protein structures per year. Over the first three years, the SGC is targeting 400 proteins that have relevance to human health and disease, such as proteins associated with diabetes, cancer, and infectious diseases such as malaria. Targets are also chosen based on interest from the academic and pharmaceutical communities, expertise within the Consortium and scientific impact. ________________________________ Johan Weigelt, Ph.D., M.Sc. Chief Scientist Karolinska Institutet MBB/Structural Genomics Consortium 171 77 Stockholm, Sweden http://sgc.ki.se/ Tel: +46 8 524 86840 Mob: +46 70 245 2868 Fax: +46 8 524 86868 [EMAIL PROTECTED]
